search
Back to results

Honey Products for Cancer Patients With Oral Mucositis: a Randomized Controlled Trial

Primary Purpose

Oral Mucositis

Status
Unknown status
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
honey
propolis
Sponsored by
Taipei Medical University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Oral Mucositis focused on measuring head and neck cancer, mucositis, honey, Taiwanese green propolis, intelligent care

Eligibility Criteria

20 Years - 100 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age≧20 years old
  • diagnosed as head and neck cancer patients
  • Plan to Receive radiation therapy
  • Consciousness, ability to complete research assessment and willing to participate in research
  • Patients can be communicated in Mandarin and Taiwanese, and complete the questionnaire on their own or with the help of researchers.

Exclusion Criteria:

  • History of allergic to honey, propolis, various pollen, alcohol
  • People with mental disorders or cognitive dysfunction
  • Diabetes mellitus
  • Critical of end of life patient

Sites / Locations

  • Taipei Medical UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

No Intervention

Arm Label

honey

propolis

control

Arm Description

Honey, 10 grams per pack, calories 33.4 calories, protein 0.05 grams, fat 0.07 grams, fructose + glucose 7.0 grams, sodium 0 mg. Usage is three times a day after three meals. After oral care is required before use, use 10 grams of longan honey, circulate in the oral cavity for at least 30 seconds, and slowly swallow. Do not eat, drink, or gargle within 30 minutes of use.

Oil-soluble green propolis, propolis 100 mg / mL, dilute green propolis 200 times with edible oil, drink 0.5 mL each time, 3 times a day (a total of 50 mg). Usage: three times a day, after three meals. After oral care is required before use, draw about 0.5ml of green propolis into the mouth, circulate in the oral cavity for at least 30 seconds, and slowly swallow. Do not eat, drink or gargle within 30 minutes of use.

Routine care to encourage oral care three times a day.

Outcomes

Primary Outcome Measures

oral mucositis
measurement tool: National Cancer Institute Common Terminology Criteria for Adverse Events and The World Health Organization grading system

Secondary Outcome Measures

Numerical Rating Scale
measurement tool:Numerical Rating Scale,for pain status, range from 0 to 10, 10 was the most pain, 0 was no pain.
Xerostomia
measurement tool: Xerostomia Questionnaire
Functional Assessment of Cancer Therapy Scale- Head and Neck
measurement tool : Functional Assessment of Cancer Therapy Scale- Head and Neck, for patient's Quality of life (QoL), range from 0 to 100, score 100 means better outcome.
fatigue--Brief-Fatigue Inventory
measurement tool: Brief-Fatigue Inventory, range 0 to 10, 10 was the worst fatigue.
fatigue--Visual Analogue Scale
measurement tool: Visual Analogue Scale for fatigue, range 0 to 10, 10 was the worst fatigue.
IL-1, IL-6, IL-10,TNF
The patient collected this saliva before the start of radiotherapy, on the 7th, 14th, 21st day and at the end of radiation therapy, a total of 5 tubes of saliva at a time

Full Information

First Posted
May 3, 2020
Last Updated
May 22, 2020
Sponsor
Taipei Medical University
search

1. Study Identification

Unique Protocol Identification Number
NCT04382079
Brief Title
Honey Products for Cancer Patients With Oral Mucositis: a Randomized Controlled Trial
Official Title
Effects of Honey and Propolis on Head and Neck Cancer Patients With Oral Mucositis: a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2020
Overall Recruitment Status
Unknown status
Study Start Date
April 8, 2020 (Actual)
Primary Completion Date
April 15, 2021 (Anticipated)
Study Completion Date
April 15, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Taipei Medical University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The investigators plan to conduct a 3-year pioneering care research project for mucositis in cancer patients. These include: (1) an analysis of the incidence and severity of mucositis, severity, treatment methods, and treatment costs; (2) an RCT comparing the effectiveness of honey, Taiwan green propolis, and usual care in mucositis of cancer patients; (3) monitoring of related symptom changes using a smart bracelet device; (4) a measurement of IL-1, IL-6, IL-10, and TNF in saliva and (4) modeling of the trend of mucositis for alertness and search of essential parameters of the complications.
Detailed Description
Mucositis is common among cancer patients receiving radiotherapy and chemotherapy. A total of 80-100% of the patients are suffering from the mucositis pain; their regular dieting is disturbed, nutritional status deteriorated, and even treatment discontinued. Some self-paid medications like glutamine have been used to prevent mucositis before and during radiotherapy/chemotherapy. However, the cost of glutamine is relatively high (NT15,000 month/person) and its treatment efficacy and side effects are still to be determined. Randomized controlled trials (RCTs) and experiments have shown that honey and propolis may be used for the management of mucositis. Taiwan is a country of rich agriculture with unique bee products among which the longan honey demonstrates the most significant antibacterial effects; the green propolis has also been proved to comprise antibacterial, anti-inflammatory, and antioxidant effects. However, none of these propolis products have been specifically trialed for the management of mucositis of cancer patients. Bee products have been concerned as potential sources of natural antioxidants such as flavonoids, phenolic acids, and terpenoids. Their potential treatment effects have caught the attention of the medical community. Accumulating evidence is supporting the use of bee products in mucositis caused by chemotherapy, radiotherapy, or both. However, systematic review and meta-analysis have suggested a low quality of the included RCTs, and this affects the applicability of the evidence in the real clinical scenario. The investigators plan to conduct a 3-year pioneering care research project for mucositis in cancer patients. These include: (1) an analysis of the incidence and severity of mucositis, severity, treatment methods, and treatment costs; (2) an RCT comparing the effectiveness of honey, Taiwan green propolis, and usual care in mucositis of cancer patients; (3) monitoring of related symptom changes using a smart bracelet device; (4) a measurement of IL-1, IL-6, IL-10, and TNF in saliva and (4) modeling of the trend of mucositis for alertness and search of essential parameters of the complications. In the first year, our project will focus on the analysis of the incidence and severity of mucositis, treatment methods, and treatment costs. In the second year, the planned RCT will be carried out and changes in heart rate, stress, and fatigue of the patients are to be collected using the smart bracelet. In the third year, the investigators will conduct a deep machine learning of the clinical and serial test data to predict the changes in symptoms. The modeling is anticipated to provide important parameter combinations that assist the alerting of possible severe complications. The overall findings of this project shall the strategical references for applying bee products in the prevention and treatment of mucositis in cancer patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Oral Mucositis
Keywords
head and neck cancer, mucositis, honey, Taiwanese green propolis, intelligent care

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
150 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
honey
Arm Type
Experimental
Arm Description
Honey, 10 grams per pack, calories 33.4 calories, protein 0.05 grams, fat 0.07 grams, fructose + glucose 7.0 grams, sodium 0 mg. Usage is three times a day after three meals. After oral care is required before use, use 10 grams of longan honey, circulate in the oral cavity for at least 30 seconds, and slowly swallow. Do not eat, drink, or gargle within 30 minutes of use.
Arm Title
propolis
Arm Type
Experimental
Arm Description
Oil-soluble green propolis, propolis 100 mg / mL, dilute green propolis 200 times with edible oil, drink 0.5 mL each time, 3 times a day (a total of 50 mg). Usage: three times a day, after three meals. After oral care is required before use, draw about 0.5ml of green propolis into the mouth, circulate in the oral cavity for at least 30 seconds, and slowly swallow. Do not eat, drink or gargle within 30 minutes of use.
Arm Title
control
Arm Type
No Intervention
Arm Description
Routine care to encourage oral care three times a day.
Intervention Type
Dietary Supplement
Intervention Name(s)
honey
Intervention Description
Since the patient received radiation therapy, Taiwan Longan Honey has been used for a total of eight weeks. Understand the changes of oral mucositis and various symptoms during this period
Intervention Type
Dietary Supplement
Intervention Name(s)
propolis
Intervention Description
Since the patient received radiation therapy, Taiwan green propolis has been used for a total of eight weeks. Understand the changes of oral mucositis and various symptoms during this period
Primary Outcome Measure Information:
Title
oral mucositis
Description
measurement tool: National Cancer Institute Common Terminology Criteria for Adverse Events and The World Health Organization grading system
Time Frame
twelve weeks
Secondary Outcome Measure Information:
Title
Numerical Rating Scale
Description
measurement tool:Numerical Rating Scale,for pain status, range from 0 to 10, 10 was the most pain, 0 was no pain.
Time Frame
twelve weeks
Title
Xerostomia
Description
measurement tool: Xerostomia Questionnaire
Time Frame
twelve weeks
Title
Functional Assessment of Cancer Therapy Scale- Head and Neck
Description
measurement tool : Functional Assessment of Cancer Therapy Scale- Head and Neck, for patient's Quality of life (QoL), range from 0 to 100, score 100 means better outcome.
Time Frame
twelve weeks
Title
fatigue--Brief-Fatigue Inventory
Description
measurement tool: Brief-Fatigue Inventory, range 0 to 10, 10 was the worst fatigue.
Time Frame
Brief-Fatigue Inventory for two weeks.
Title
fatigue--Visual Analogue Scale
Description
measurement tool: Visual Analogue Scale for fatigue, range 0 to 10, 10 was the worst fatigue.
Time Frame
Visual Analogue Scale for fatigue for twelve weeks.
Title
IL-1, IL-6, IL-10,TNF
Description
The patient collected this saliva before the start of radiotherapy, on the 7th, 14th, 21st day and at the end of radiation therapy, a total of 5 tubes of saliva at a time
Time Frame
radiotherapy on Day 0, on the 7th, 14th, 21st day and on an average of 28 st day.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age≧20 years old diagnosed as head and neck cancer patients Plan to Receive radiation therapy Consciousness, ability to complete research assessment and willing to participate in research Patients can be communicated in Mandarin and Taiwanese, and complete the questionnaire on their own or with the help of researchers. Exclusion Criteria: History of allergic to honey, propolis, various pollen, alcohol People with mental disorders or cognitive dysfunction Diabetes mellitus Critical of end of life patient
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Tsai-Wei Huang, PhD
Phone
+88627361661
Ext
6350
Email
tsaiwei@tmu.edu.tw
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tsai-Wei Huang, PhD
Organizational Affiliation
Taipei Medical University
Official's Role
Study Chair
Facility Information:
Facility Name
Taipei Medical University
City
Taipei county
ZIP/Postal Code
110
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tsai-Wei Huang, PhD
Phone
+88627361661
Ext
6350
Email
tsaiwei@tmu.edu.tw
First Name & Middle Initial & Last Name & Degree
Shao-Ching Jen, BS

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
oral mucositis severity, fatigue, pain, quality of life
IPD Sharing Time Frame
Before radiotherapy, until 12 weeks later
IPD Sharing Access Criteria
Professor Huang will review the application to share IPD.

Learn more about this trial

Honey Products for Cancer Patients With Oral Mucositis: a Randomized Controlled Trial

We'll reach out to this number within 24 hrs